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Operational research leading to rapid national policy change: 
tuberculosis-diabetes collaboration in India
A. M. V. Kumar,1 S. Satyanarayana,1 N. C. Wilson,1 S. S. Chadha,1 D. Gupta,2 S. Nair,3 R. Zachariah,4  
A. Kapur,5 A. D. Harries6,7
The interaction between tuberculosis (TB) and dia-betes mellitus (DM) has been well documented: 
DM patients are at higher risk of developing TB, and 
individuals with both DM and TB are at higher risk of 
poor treatment outcomes.1 To address this dual bur-
den, in 2011 the World Health Organization (WHO) 
and the International Union Against Tuberculosis and 
Lung Disease (The Union) developed a collaborative 
framework for care and control of TB and DM that rec-
ommended that countries undertake several activities, 
including bidirectional screening for TB and DM.2 
However, the operational guidelines on how best to 
implement this intervention in programme settings 
were lacking.
To bridge this gap, a countrywide, multicentre op-
erational research (OR) project was designed and con-
ducted in India in 2012 by The Union South-East Asia 
office in collaboration with the Indian Revised Na-
tional Tuberculosis Control Programme (RNTCP), the 
National Programme for Prevention and Control of 
Cancer, Diabetes, Cardiovascular Diseases and Stroke 
(NPCDCS), the WHO and other stakeholders within 
the country. Financial support for meetings and for 
project coordination was provided by the World Dia-
betes Foundation (WDF). Results from this OR led to a 
national policy decision in September 2012 to rou-
tinely screen all TB patients notified under the RNTCP 
for DM in India. This decision was achieved in a short 
time frame within just a year of project conception.3,4 
What factors made this rapid translation of evidence 
to policy possible? In this article, we describe the ex-
perience of implementing this collaborative model of 
operational research that led to policy change, and 
highlight some of the main enablers.
ASPECT OF INTEREST
The timeline of key events from the conception of OR 
to the policy decision is described in Table 1. Briefly, 
it started with a national stakeholders meeting in Oc-
tober 2011 to agree broadly on the necessity for 
TB-DM collaboration and the need to generate 
high-quality evidence for programme decisions using 
well-planned OR. Key principles about where to con-
duct the OR, how to screen for DM and TB and how 
to record and report the findings were discussed and 
agreed upon.
Following this meeting, a national protocol was de-
veloped, OR sites were identified (based on their will-
ingness to participate in the study) and ethics ap-
proval was obtained for writing up the findings. Staff 
from the participating sites were then trained in 
screening, recording and reporting procedures. The 
quality of the protocol implementation was moni-
tored by supervisory visits and submitted reports were 
validated by cross-matching the data with the records. 
An interim analysis in August 2012 showed that it was 
feasible to perform bi-directional screening, and that 
screening identified a significant proportion of undi-
agnosed DM among TB patients. This led the pro-
gramme managers of the RNTCP and NPCDCS to de-
cide on the policy change in September 2012, before 
the full study results were available. After completion 
of the study, a data analysis and writing workshop was 
conducted, resulting in several publications.3,4,6 A final 
national stakeholders meeting was held soon after, at 
which the findings and policy decisions were pre-
sented to a large audience. A training manual was 
drafted for health care workers based on the experi-
ence of the OR project which details the screening 
procedures and recording and reporting mechanisms 
to be conducted under the RNTCP. The key factors 
that enabled this national policy change are sum-
marised in Table 2.
DISCUSSION
The OR project was carried out rapidly with pro-
gramme and stakeholder participation, and the find-
ings were swiftly translated into national policy. There 
were several important enabling factors. First, OR was 
conducted on a topic that was of direct relevance to 
both programmes. India has the highest burden of TB 
in the world and the second highest burden of DM,7,8 
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In 2011, bi-directional screening for tuberculosis (TB) and 
diabetes mellitus (DM) was recommended by the World 
Health Organization (WHO), although how best to imple-
ment the activity was not clear. In India, with early engage-
ment of national programme managers and all important 
stakeholders, a countrywide, multicentre operational re-
search (OR) project was designed in October 2011 and 
completed in 2012. The results led to a rapid national pol-
icy decision to routinely screen all TB patients for DM in 
September 2012. The process, experience and enablers of 
implementing this unique and successful collaborative 
model of operational research are presented.
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TABLE 1 Timelines and events leading up to national policy change on joint TB and DM collaboration in India 
Key event and timeline Description
First National Stakeholders Meeting 
(October 2011)
This was a 2-day meeting conducted under the leadership of the national programme 
managers of the RNTCP and NPCDCS and attended by 36 participants, including state 
programme managers of selected states, representatives of medical colleges caring for 
TB and DM patients and national research institutes, WHO-RNTCP national and field 
consultants, representatives of donor agencies such as WDF and USAID, and technical 
agencies such as the WHO and The Union. During this meeting, all were informed 
about the joint WHO-Union framework for TB-DM collaborative activities, reviewed 
the available in-country data on the TB-DM burden and discussed the need for 
bi-directional screening in India. A broad consensus was reached on procedures for 
screening, monitoring, recording and reporting and potential sites for conducting the 
OR. The sites were selected on the basis of a broad representation of different types of 
health facility (primary, secondary and tertiary) and countrywide coverage. It was also 
observed that minimal additional dedicated funding was needed and that this OR 
could be implemented by utilising existing resources within the two programmes 
Protocol development and ethics 
approval (November 2011)
Based on the recommendations of the national stakeholder meeting, a protocol was 
developed by the senior researchers of The Union, finalised in consultation with the 
RNTCP and NPCDCS and  submitted to the Ethics Advisory Group of The Union, Paris, 
France, with a request for expedited ethics review; approval was received within 2 
weeks. As the OR was to be implemented under routine programme conditions, the 
need for informed consent was waived. The national programme manager wrote to 
the institutional ethics committees of all the study sites describing the national 
importance of the study and requesting expedited local ethics approval
Protocol finalisation and training 
workshops (December 2011 and 
January 2012)
Two–three staff officers from each of the participating OR sites (eight tertiary care 
hospitals and eight TB units, comprising 67 peripheral health facilities working under 
the RNTCP) were involved in finalisation of the protocols and underwent training on 
the standard procedures. These trained personnel in turn trained other health care 
workers at their respective sites  
Logistics (January–February 2012) The data collection formats (patient treatment cards, registers, quarterly report forms) 
were printed and couriered to the study sites in the month of January 2012. While 
most sites had facilities for performing blood glucose tests, glucometers were 
procured and supplied to some of the sites. 
OR implementation and data collection  
(January–September 2012)
Implementation of activities started in the first quarter of 2012, with some sites 
starting in January and others in February or March. It was agreed that data would be 
reported in quarterly (Q) cohorts: Q1-2012 (January–March), Q2-2012 (April–June), 
and Q3-2012 (July–September) via e-mail to the national programmes, with a copy to 
The Union for collation. The quarterly reports had to be submitted in standardised 
formats within a month of the end of the quarter, and this was monitored
Site supervision (January–September 
2012)
Supervisory field visits to OR sites were undertaken jointly by the RNTCP and The 
Union to oversee protocol implementation, identify logistic challenges and initiate 
mid-course corrections, if required
Interim analysis and appraisal of the 
findings by national programme 
managers (August 2012)
At the request of the national programme managers, an interim analysis of the data 
was undertaken and results were shared in July 2012. The findings were convincing, 
thus persuading the national programme manager(s) to consider wider and national 
policy decisions
Policy decision (September 2012) A national policy decision on screening all TB patients for DM was taken and formally 
communicated to all states and districts. A training module, based on the protocol 
used for the OR, was developed to train the health care workers in implementing the 
new policy, with operational details of recording and reporting under routine settings 
being agreed and shared with the states
First data analysis and writing workshop 
(end of October–early November 
2012) 
Data analysis and paper writing was undertaken in a 4-day workshop conducted and 
attended by the representatives of all the study sites. With our philosophy of being 
inclusive, everyone involved in the OR was invited to co-author on the papers.5 The 
papers were submitted for publication in an international journal and published in 
May 20133,4 
Second data analysis and writing 
workshop  
(April 2013)
Individual sites were supported through another 4-day workshop in 2013 to analyse 
and write up their experiences at site level: these findings were published in a TB-DM 
supplement in Public Health Action in December 2013
Final national stakeholders meeting 
(April 2013)
A half-day national meeting was held with 42 participants, including the national 
programme managers, representatives of medical colleges and national research 
institutes, WHO-RNTCP national and field consultants, representatives of donor 
agencies (such as WDF) and technical agencies (such as the WHO and The Union). 
The purpose was to present and discuss the results of the OR, the implications of the 
findings and the policy decisions
TB = tuberculosis; DM = diabetes mellitus; RNTCP = Revised National Tuberculosis Control Programme; NPCDCS = National Programme for Pre-
vention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke; WHO = World Health Organization; WDF = World Diabetes Founda-
tion; USAID = United States Agency for International Development; The Union = International Union Against Tuberculosis and Lung Disease; OR = 
operational research.
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and interaction between the two diseases is of major public health 
importance.
Second, the national programme managers were involved 
from the conception of the OR to the dissemination of findings 
and eventual publication. The approach of involving them early 
on in the process fostered their sense of ownership and responsi-
bility, which in our opinion was key to making rapid progress. 
This is in contrast to much research in which the publication 
milestone has become the end-point, with little consideration 
given to what happens afterwards. As such, engagement with pro-
gramme managers and policy makers is not seen as a priority.9,10
Third, the participation of key stakeholders (for example, tech-
nical and donor agencies) working in TB and DM care in the 
country helped to achieve a national consensus and wide owner-
ship of the results, thus creating many advocates for policy 
change.
Fourth, there was high-quality technical assistance from senior 
researchers of The Union, the WHO and national research insti-
tutes right from protocol development to data analysis and draft-
ing scientific manuscripts.
Ethics approval, which often delays research projects, was rap-
idly obtained. As there was approval from the Ethics Advisory 
Group of The Union and a communication from the national 
programme manager(s) reiterating the national importance of the 
OR, the need to assess feasibility of bidirectional screening under 
routine conditions and the fact that the study involved extracting 
data from records with no patient interview, the institutional eth-
ics committees of the participating sites also expedited ethics ap-
proval and waived the need for individual informed consent.
Fifth, the inclusive philosophy meant that all stakeholders 
were involved at the different stages of the research process and 
were deservingly credited as co-authors of papers in line with the 
criteria of the International Committee of Medical Journal Edi-
tors.11 While it was a challenge to achieve consensus among such 
a large group, innovative approaches were employed as described 
elsewhere.5
Sixth, collaborative research projects involving multiple part-
ners often face implementation delays for a variety of reasons. We 
undertook several pre-emptive measures to mitigate delays, in-
cluding prior agreement and strict monitoring of adherence to 
project timelines, supervisory site visits and leadership by the na-
tional programmes, all of which helped to identify and resolve 
logistic issues in a timely fashion.
Finally, The Union (a non-governmental organisation) under-
took the responsibility for coordinating the project logistics — 
support that was very much welcomed by the national pro-
gramme managers. With the policy and operational guidance for 
implementation now in place, the next major challenges are to 
ensure that it is implemented on the ground and to monitor its 
impact on health outcomes. While TB services are available 
throughout the country, the same cannot be said of DM care ser-
vices, which are currently available only in around 100 districts. 
The success of this joint collaboration will thus depend heavily 
on the pace of scale-up of the NPCDCS, which aims to expand 
DM care services to the entire country by 2017.
In conclusion, this model of operational research, which fos-
tered a high sense of ownership and which was propelled by the 
national programme managers in collaboration with the techni-
cal and donor agencies, worked rapidly and efficiently. This expe-
rience offers useful lessons for the future.
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TABLE 2 Enabling factors for rapid translation of evidence to policy on TB and DM collaboration, India 
Enabling factors
• Direct relevance of the operational research topic to the national programmes and their formal ratification
• Engagement of national programme managers during conception of the research questions and throughout all stages of the operational research
• A philosophy of being inclusive that fostered participation by all stakeholders
• Partnership model: collaboration between international technical organisations, donor agencies and national institutes under the stewardship of the 
national programmes
• High-quality technical assistance in design, conduct, analysis and publication of research
• Expedited ethics review and approval
• Ensuring adherence to agreed timelines by all stakeholders by providing ongoing support 
• Effective dissemination including interim analysis and direct appraisal of programme managers with the research findings 
• Fast-tracked scientific writing for publication
• Project coordination and efficient logistic support by a non-governmental organisation
TB = tuberculosis; DM = diabetes mellitus.
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En 2011, un double dépistage de la tuberculose (TB) et du diabète 
(DM) a été recommandé par l’Organisation Mondiale de la Santé 
(OMS), mais il n’a pas été précisé clairement comment mettre en 
œuvre au mieux cette activité. En Inde, grâce à l’engagement précoce 
des directeurs de programmes nationaux et de tous les partenaires 
importants, un projet national de recherche opérationnelle (OR) 
multicentrique a été conçu en octobre 2011 et achevé en 2012. Les 
résultats ont rapidement amené à une décision politique nationale de 
dépister en routine tous les patients TB à la recherche de DM en 
septembre 2012. Cet article présente la procedure et l’expérience de 
ceux qui ont mis en œuvre ce modèle collaboratif de recherche 
opérationnelle assez unique et fructueux.
En el 2011, la Organización Mundial de la Salud recomendó la 
detección bidireccional de la tuberculosis (TB) y la diabetes sacarina 
(DM), aunque no fue claro cuál sería el mejor mecanismo de 
ejecución de la iniciativa. En la India, con la participación temprana 
de los gestores del programa nacional y todos los principales 
interesados directos, se formuló un proyecto multicéntrico de 
investigación operativa de ámbito nacional en octubre del 2011 y 
se completó en el 2012. Los resultados llevaron a una rápida 
decisión política de alcance nacional en septiembre del 2012, de 
practicar la detección sistemática de la DM en todos los pacientes 
con diagnóstico de TB. En el presente artículo se describe el 
proceso, las experiencias y los factores facilitadores de la ejecución 
de este excepcional y eficaz modelo colaborativo de investigación 
operativa.
